264 related articles for article (PubMed ID: 23216791)
1. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
Rezaei M; Friedrich K; Wielockx B; Kuzmanov A; Kettelhake A; Labelle M; Schnittler H; Baretton G; Breier G
Breast Cancer Res; 2012 Dec; 14(6):R154. PubMed ID: 23216791
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
[TBL] [Abstract][Full Text] [Related]
3. The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.
Rezaei M; Cao J; Friedrich K; Kemper B; Brendel O; Grosser M; Adrian M; Baretton G; Breier G; Schnittler HJ
Histochem Cell Biol; 2018 Jan; 149(1):15-30. PubMed ID: 29143117
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y
Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957
[TBL] [Abstract][Full Text] [Related]
7. The Influence of VE-Cadherin on Adhesion and Incorporation of Breast Cancer Cells into Vascular Endothelium.
Brock T; Boudriot E; Klawitter A; Großer M; Nguyen TTP; Giebe S; Klapproth E; Temme A; El-Armouche A; Breier G
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205118
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cadherins in cancer.
Breier G; Grosser M; Rezaei M
Cell Tissue Res; 2014 Mar; 355(3):523-7. PubMed ID: 24619142
[TBL] [Abstract][Full Text] [Related]
10. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
11. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
[TBL] [Abstract][Full Text] [Related]
12. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
[TBL] [Abstract][Full Text] [Related]
13. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
[TBL] [Abstract][Full Text] [Related]
14. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
15. The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells.
Sahni A; Arévalo MT; Sahni SK; Simpson-Haidaris PJ
Int J Cancer; 2009 Aug; 125(3):577-84. PubMed ID: 19358279
[TBL] [Abstract][Full Text] [Related]
16. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
17. VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene Expression.
Morini MF; Giampietro C; Corada M; Pisati F; Lavarone E; Cunha SI; Conze LL; O'Reilly N; Joshi D; Kjaer S; George R; Nye E; Ma A; Jin J; Mitter R; Lupia M; Cavallaro U; Pasini D; Calado DP; Dejana E; Taddei A
Circ Res; 2018 Jan; 122(2):231-245. PubMed ID: 29233846
[TBL] [Abstract][Full Text] [Related]
18. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.
Benzina S; Beauregard AP; Guerrette R; Jean S; Faye MD; Laflamme M; Maïcas E; Crapoulet N; Ouellette RJ; Robichaud GA
Oncotarget; 2017 Feb; 8(7):12052-12066. PubMed ID: 28076843
[TBL] [Abstract][Full Text] [Related]
19. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
20. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
